EBS News and Press, Emergent Biosolutions Inc. From 11/23/23

2023-11-23 08:10:13 ET Summary Emergent BioSolutions produces NARCAN nasal spray, traveler's package vaccines and other vaccines periodically stockpiled by the government. NARCAN is experiencing substantial growth due to demand from the opioid epidemic and has received OTC approva...

2023-11-17 10:00:08 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Curis, Emergen...

2023-11-09 03:41:24 ET More on Emergent Biosolutions Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial For further details see: Emergent Biosolutions reports Q3 results; updates FY23 guidance

2023-11-08 23:06:03 ET Emergent BioSolutions Inc. (EBS) Q3 2023 Earnings Conference Call November 8, 2023, 5:00 PM ET Company Participants Haywood Miller - Interim Chief Executive Officer Paul Williams - Senior Vice President and Head, Product Business Rich Linda...

2023-11-08 23:00:21 ET Image source: The Motley Fool. Emergent BioSolutions (NYSE: EBS) Q3 2023 Earnings Call Nov 08, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions (EBS) Q3 2023 Earnings Call Tran...

Third Quarter 2023 Total Revenues of $271M, above the prior guidance range Third Quarter 2023 Pre-Tax Loss of  $(266)M and Adjusted EBITDA (2) of $20M Updates FY 2023 guidance GAITHERSBURG, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Emergent Biosolutions Inc. (EBS) is expected to report $0.05 for Q3 2023

GAITHERSBURG, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) has rescheduled its conference call to Wednesday, November 8, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for...

GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 2, 2023, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for fu...